The DOI matches its Crossref record.
Hypoglycemia in the Diabetes Control and Complications Trial
Abstract
A total of 1,441 patients with IDDM were randomly assigned to receive either intensive (n = 711) or conventional (n = 730) diabetes therapy in the Diabetes Control and Complications Trial (DCCT). The patients were followed for an average of 6.5 years. Subjects were instructed to report all episodes of suspected severe hypoglycemia to their health care team. In addition, at quarterly follow-up visits, each subject was asked about the occurrence of severe hypoglycemia. There were 3,788 episodes of severe hypoglycemia (requiring assistance); 1,027 of these episodes were associated with coma and/or seizure. A total of 65% percent of patients in the intensive group vs. 35% of patients in the conventional group had at least one episode of severe hypoglycemia by the study end; the overall rates of severe hypoglycemia were 61.2 per 100 patient-years vs. 18.7 per 100 patient-years in the intensive and conventional treatment groups, respectively, with a relative risk (RR) of 3.28. The relative risk for coma and/or seizure was 3.02 for intensive therapy. The increased risk with intensive treatment persisted over each of the 9 years of follow-up in the DCCT and over the calendar years 1984–1993 during which the study was conducted. When baseline patient characteristics were examined for effects on the risk of severe hypoglycemia, the relative risk of hypoglycemia for intensive versus conventional treatment was ≥2 for all subgroups. Several subgroups defined by baseline characteristics, including males, adolescents, and subjects with no residual C-peptide or with a prior history of hypoglycemia, had a particularly high risk of severe hypoglycemia in both treatment groups. Analyses of the cumulative incidence of successive episodes indicated that intensive treatment was also associated with an increased risk of multiple episodes within the same patient (e.g., 22% experienced five or more episodes of severe hypoglycemia within the first 5 years of follow-up vs. 4% in the conventional group). Within both treatment groups, patients who experienced severe hypoglycemia were at increased risk of subsequent episodes. Approximately 30% of patients in each group experienced a second episode within the 4 months following the first episode of severe hypoglycemia. Within each treatment group, the number of prior episodes of hypoglycemia was the strongest predictor of the risk of future episodes, followed closely by the current HbA1c value. After adjustment for the current quarterly HbA1c level, intensive treatment was still associated with a significantly increased risk of hypoglycemia, indicating that the increased risk with intensive treatment is not completely explained by differences in HbA1c values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have established that intensive glycemic therapy prevents or delays the microvascular complications-retinopathy, nephropathy, and neuropathy-of diabetes (122, 123, 131, 144, 145), albeit at the expense of an increased frequency of hypoglycemia (117, 118, 122, 123, 132, 133, 144, 145).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [133]
In the citing paper
“A glucose of <70 mg/dL (3.9 mmol/L) is the classic threshold for hypoglycemia based on physiologic glucose regulation and neuroendocrine response in persons without DM.1197”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1197]
Citations
Cites
Still being checked.
Cited by
Items 601–700 of 779
Gilliam, L. K., Parker, M. M., Moffet, H. H., Lee, A. K., & Karter, A. J. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0493 · Cited by 4
Heinrich, M., Maison, N., Achenbach, P., Assfalg, R., Braig, S., Böcker, D., Dunstheimer, D., Ermer, U., Gavazzeni, A., Gerstl, E.-M., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12739 · Cited by 4
Self-citationSmetana, G. W., Nathan, D. M., Dugdale, D. C., & Burns, R. B. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0946 · Cited by 8
A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors
Ábel, T. (2011) · InTech eBooks · doi:10.5772/23604 · Cited by 4
Fear of hypoglycaemia in patients with type 1 diabetes
Patrakeeva, E. M., Dunicheva, M. N., & Zalevskaya, A. G. (2014) · Diabetes Mellitus · doi:10.14341/dm2014266-75 · Cited by 6
Şakalak, H., Ulaşan, M., Yavuz, E., Çamlı, Ş. T., & Yavuz, M. S. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2767-6 · Cited by 4
Plavšić, L., Mitrović, K., Todorovic, S., Vuković, R., Milenković, T., & Zdravković, D. (2014) · Vojnosanitetski pregled · doi:10.2298/vsp130422039p · Cited by 4
Nakashima, E., Kuribayashi, N., Ishida, K., Taketsuna, M., Takeuchi, M., & Imaoka, T. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0411 · Cited by 4
Colberg, S. R. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.1.10 · Cited by 4
Fritzen, K., Gutschek, B., Coucke, B., Zakrzewska, K. E., Hummel, M., & Schnell, O. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818758104 · Cited by 4
A general view of epidemiology of hypoglycemia in type 1 and type 2 diabetes mellitus
Brož, J., & Urbanová, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.050 · Cited by 5
Clayton, D., Woo, V. C., & Yale, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.088 · Cited by 6
RetractedBala, C. G., Rusu, A., Moise, M., & Román, G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0020 · Cited by 4
Avari, P., Ramli, R., Reddy, M., Oliver, N. S., & Fothergill, R. T. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0439-3 · Cited by 4
How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
Chon, S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.2.114 · Cited by 4
Steinmetz, J., Nielsen, S., & Rasmussen, L. S. (2006) · European Journal of Emergency Medicine · doi:10.1097/00063110-200610000-00019 · Cited by 3
Multilevel Model of Type 1 Diabetes Mellitus Patients for Model-Based Glucose Controllers
García-Gabín, W., & Jacobsen, E. W. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700125 · Cited by 5
Ganz, M. L., Li, Q., Wintfeld, N., Lee, Y.-C., SORLI, C. H., & Huang, J. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1074891 · Cited by 4
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 7
Management of the patient with diabetes mellitus in the dental office
Mealey, B. L. (2014) · doi:10.1002/9781118887837.ch5 · Cited by 4
Glucagon: Are we missing a (life‐saving) trick?
Niessen, S. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00809.x · Cited by 4
Burnside, M. J., Ellis, K. L., Jones, T. W., Zomer, E., Zoungas, S., Abraham, M. B., Smith, G. J., Irwine, K., Davis, E. A., & Taplin, C. E. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251387160 · Cited by 3
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Edelman, S. V., Garg, S. K., & Kolterman, O. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0506 · Cited by 3
Larocque, J. C., Gardy, S., Sammut, M. J., McBey, D. P., & Melling, C. W. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273701 · Cited by 3
Tremamunno, S., Tartaglione, L., Telesca, A., Rizzi, A., Felici, T., Mazzotta, F. A., Vita, A. D., Rizzo, E., Cambise, N., Belmusto, A., et al. (2024) · Endocrine · doi:10.1007/s12020-023-03651-w · Cited by 5
Altered Mental Status: Hypoglycemia
Petrikas, R., & Schumann, L. L. (1998) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.1998.tb01215.x · Cited by 3
Management of Glycemia in Diabetic Patients with Stage IV and V Chronic Kidney Disease
Roche-Recinos, A., Charlap, E., & MARKELL, M. S. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0600-y · Cited by 3
Insulin lispro:a new quick-acting insulin analogue
Gale, E. A. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.9.1247 · Cited by 3
Gabbay, M. A. L., & Dib, S. A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000700022 · Cited by 3
Case Study: Seizures and Hypoglycemia
Brennan, M. R., & Whitehouse, F. W. (2012) · Clinical Diabetes · doi:10.2337/diaclin.30.1.23 · Cited by 3
Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes
Moutairou, A., Roussel, R., Charbonnel, B. H., Lèye, A., Detournay, B., Mohammedi, K., & Potier, L. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.009 · Cited by 3
Pharmacological aspects of closed loop insulin delivery for type 1 diabetes
Uduku, C. N., & Oliver, N. S. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.07.006 · Cited by 5
Chen, J. W., Lauritzen, T., Bojesen, A., & Christiansen, J. S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00557.x · Cited by 3
Nomoto, H., Furusawa, S., Nakamura, A., Takeuchi, J., Nagai, S., Yokoyama, H., Sakuma, I., Taneda, S., Kurihara, Y., Aoki, S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056885 · Cited by 4
Current Status of Islet Transplantation
Cravedi, P., Ruggenenti, P. L., Remuzzi, A., & Remuzzi, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398523-1.00040-9 · Cited by 3
Programmable Implantable Insulin Infusion Devices and Diabetes Care
Charles, M. A. (1999) · Diabetes Technology & Therapeutics · doi:10.1089/152091599317639 · Cited by 3
Norris, A. W., & Wolfsdorf, J. I. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch18 · Cited by 3
Norris, A. W., & Wolfsdorf, J. I. (2005) · Clinical Pediatric Endocrinology · doi:10.1002/9780470987117.ch21 · Cited by 15
A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target
Lu, J., Chen, D., Lin, B., Liu, Z., Yang, Y., He, L., Yan, J., Yang, D., & Xu, W. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01713-9 · Cited by 5
Thanabalasingham, G., Lumb, A. N., Murphy, H. R., Scanlon, P. H., Buckingham, J., Tesfaye, S. H., Pokrajac, A., Choudhary, P., Divilly, P., Dhatariya, K., et al. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198851899.003.0015 · Cited by 2
Severe hypoglycemia and cardiovascular disease
Tak, S., & Jain, A. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100357 · Cited by 2
Epidemiology and Pathogenesis of Type 2 Diabetes
Robertson, R. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_3 · Cited by 2
(2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00583-2 · Cited by 2
An overview of non-insulin adjunctive therapies for Type 1 diabetes
Ballav, C., & Gough, S. C. L. (2014) · Diabetes Management · doi:10.2217/dmt.14.38 · Cited by 2
Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
Peterson, G. M. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s3401 · Cited by 2
Implications of the 2008 update from the collaborative islet transplant registry
Hirshberg, B. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0051-4 · Cited by 2
Adverse Drug Reactions and Drug-drug Interactions
Benton, W. W., Brothers, A. W., Kirk, C. J., Irby, G. A. L., & Rubino, C. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10118-1 · Cited by 2
Aktueller Stand der klassischen Insulinpumpentherapie
Siegmund, T., & Thomas, A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0205-y · Cited by 3
Manousaki, D., Deladoëy, J., Geoffroy, L., & Olivier, P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00084 · Cited by 2
A New Paradigm for Control of Diabetes
Dickey, R. A., & Feld, S. (2002) · Endocrine Practice · doi:10.4158/ep.8.1.65 · Cited by 2
Yazigi, A., & Andréelli, F. (2007) · Cahiers de Nutrition et de Diététique · doi:10.1016/s0007-9960(07)88697-4 · Cited by 2
Artificial Pancreas: The Argentine Experience
Colmegna, P. H., Garelli, F., Fushimi, E., Moscoso-Vásquez, M., Rosales, N., García-Violini, D., Battista, H. D., & Sánchez‐Peña, R. (2019) · Science Reviews - from the end of the world · doi:10.52712/sciencereviews.v1i1.7 · Cited by 2
Hsu, W. C., Aiello, L. M., Barnett, D. M., & Cavallerano, J. D. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50324-6 · Cited by 2
Counterregulatory Deficiencies in Diabetes
McCrimmon, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch3 · Cited by 2
Neurological Sequelae of Hypoglycaemia
Perros, P., & Bjørgaas, M. R. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch15 · Cited by 2
Hypoglycaemia in Children with Diabetes
Matyka, K. A. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch10 · Cited by 2
Immunotherapy of Type-1 Diabetes: Immunoprevention and Immunoreversal
Waldron-Lynch, F., & Herold, K. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_18 · Cited by 2
Round table on hypoglycaemia in diabetic children
Soltész, G. (1998) · Acta Paediatrica · doi:10.1080/080352598750030564 · Cited by 2
Sensing Glucose and Other Metabolites in Skin
Genina, E. A., Larin, K. V., Bashkatov, A. N., & Tuchin, V. V. (2012) · Wiley eBooks · doi:10.1002/9783527643981.bphot062 · Cited by 2
Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2002) · Wiley eBooks · doi:10.1002/9780470693513.ch7 · Cited by 2
Self‐monitoring of Blood Glucose
Skyler, J. S. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0805 · Cited by 2
Detection of Hypoglycemia using ear-EEG
Cabrera, A. F., Gram-Kampmann, E.-M., Kappel, S. L., Remvig, L. S., Toft, H. O., Madsen, R. E., Juhl, C. B., Kidmose, P., & Rank, M. L. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10781651 · Cited by 1
The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance
Attia, N., Noaim, K. I. A., Khadora, M. M., Fifi, S. H. A., Alwan, I. A. A., Thalange, N. K. S., & Babiker, A. M. I. (2025) · Pediatric Diabetes · doi:10.1155/pedi/6859764 · Cited by 1
Tricò, D., Jiang, L., Spicer, D., Page, K., Aguiar, R. B. D., Naik, S., Savoye, M., Caseria, D. M., Arora, J., Mason, G. F., et al. (2026) · Diabetes · doi:10.2337/db26-0293 · Cited by 2
Oliver, N. S., Gehr, B., Lal, R., van Dijk, P. R., & Renard, É. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71054 · Cited by 1
Intervenção nutricional padronizada em pacientes hipoglicêmicos hospitalizados
Machado, S. R., Rodrigues, A. L. C. C., da Silva, S. C., Alvim, R. D. O., & Santos, P. C. J. L. (2012) · Revista gaúcha de enfermagem · doi:10.1590/s1983-14472012000100009 · Cited by 1
Limitations of Nontransplant Treatment Options for Type 1 Diabetes Mellitus
Kendall, D. M., & Bergenstal, R. M. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_3 · Cited by 1
Genetically engineered insulin and its pharmaceutical analogues
Гусаров, Д. А., Gusarova, V. D., Bayramashvili, D. I., & Миронов, А. Ф. (2008) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750808040057 · Cited by 1
Psychometric Properties of the Swedish Version of the Fear of Complications Questionnaire
Olsen, M. V., Anderbro, T., Amsberg, S., Leksell, J. K., Moberg, E., Lisspers, J., Guðbjörnsdóttir, S., & Johansson, U. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.44008 · Cited by 1
¿De qué nos sirve evaluar las tendencias del perfil glucémico ambulatorio?
Izquierdo, E. S. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.06.002 · Cited by 1
Hemodialysis Associated with Severe and Unpredictable Hypoglycemia
Hisano, Y., Kaneto, H., Kimura, T., Ota, T., Kamao, T., Uno, M., Mizushima, T., Mune, T., & Kaku, K. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4495 · Cited by 1
Kardiovaskuläre Effekte der Insulintherapie
Pfohl, M. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0088-3 · Cited by 1
Moutairou, A., Roussel, R., Charbonnel, B. H., Boustany, R. E., Nicolas, A., Lèye, A., Mohammedi, K., Marre, M., Detournay, B., & Potier, L. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.08.001 · Cited by 2
Malek, R., Arbouche, Z., Belhadj, M., Nicolucci, A., & Gari, S. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30070-6 · Cited by 1
Hypoglycemia and Hypoglycemic Syndromes
Davis, S. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00047-2 · Cited by 2
Management of Diabetes Mellitus in Children
Wolfsdorf, J. I., & Botero, D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00049-6 · Cited by 1
Fear of hypoglycaemia in paediatric diabetes: a literature review
Fernando, A., & Patel, V. (2021) · British Journal of Diabetes · doi:10.15277/bjd.2021.286 · Cited by 2
Nonproliferative and Proliferative Diabetic Retinopathy
Sun, J. K., & Aiello, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_24-1 · Cited by 2
Evolución histórica de las moléculas de insulina empleadas en el tratamiento de la diabetes
Gomez-Perez, F. J., Cárdenas-Fragoso, J. L., Ríos-Torres, J. M., & Tovar-Méndez, V. H. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m21000017 · Cited by 1
Hypoglycemia—The Major Barrier to Good Glycemic Control
Davis, S. N., & Dunn, J. P. (2006) · US Endocrinology · doi:10.17925/use.2006.00.1.2f · Cited by 1
Diabete e declino cognitivo: dall’epidemiologia ai test diagnostici
Ferrazza, G., Nucera, A., & Rizza, S. (2022) · il Diabete · doi:10.30682/ildia2204b · Cited by 1
Diabetes: a Overview on Metabolic Disorder of Carbohydrates Metabolism
-, M. B. K., -, K. V. G., Khedkar, A. N., & -, V. K. M. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i06.8624 · Cited by 1
Development of Smart Contact Lenses for Ophthalmic Glucose Monitoring
Badugu, R., Lakowicz, J. R., & Geddes, C. D. (2007) · Springer eBooks · doi:10.1007/0-387-33015-1_17 · Cited by 1
Li, W., He, X., Zhang, T., Xiang, G., Ran, J., Peng, C., & Zhang, H. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.025 · Cited by 1
Hypoglycémie et risque cardiovasculaire dans le diabète de type 1 et de type 2
Sultan, A. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30074-8 · Cited by 1
Physical activity level and hypoglycemia in type 1 diabetes patients
Duarte, C. K., Rodrigues, T. D. C., Merker, A. J. S., Brauner, F. D. O., & de Almeida, J. C. (2016) · Clinical & Biomedical Research · doi:10.4322/2357-9730.62173 · Cited by 1
Cryer, P. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00034-4 · Cited by 5
Predictive low glucose suspend systems
Forlenza, G. P., & Ekhlaspour, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00014-4 · Cited by 1
Berlanda, G., Teló, G. H., Krug, B. C., Scheffel, R. S., Pasinato, B. P. R., Iorra, F. D. Q., dos Reis, J. G., Picon, P. D., & Schaan, B. D. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000332 · Cited by 3
Microdialysis as a Monitoring System for Human Diabetes
Ciechanowska, A., Wojcicki, J. M., Maruniak‐Chudek, I., Ładyżyński, P., & Krzymień, J. (2011) · Wiley eBooks · doi:10.1002/9781118011294.ch12 · Cited by 1
Allotransplantation of Pancreatic Islets
Juszczak, M. T., & Johnson, P. (2012) · Wiley eBooks · doi:10.1002/9781118483664.ch6 · Cited by 1
Newer Insulins in Search of a Niche
Majumdar, S. K., & Barrett, E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00011 · Cited by 1
Treating hypoglycemia in children with diabetes: A simple game of “skittles”?
Daneman, D. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00671.x · Cited by 1
Nebenwirkung der Diabetestherapie - Hypoglykämische Notfälle bei Typ 1- und Typ 2-Diabetespatienten
Reinsch, B., Ehren, M., & Pfohl, M. (2003) · Notfall Medizin · doi:10.1055/s-2003-38958 · Cited by 1
Night‐time only insulin pump therapy in young children with type 1 diabetes mellitus
Razeghi, S., Schubert, V., Knerr, I., Plank, C., & Zimmermann, T. (2002) · Practical Diabetes · doi:10.1002/pdi.401 · Cited by 1
Allegretti, P. J., & Carroll, M. (2002) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2002.35507 · Cited by 1
Cryer, P. E., & Frier, B. M. (2004) · International Textbook of Diabetes Mellitus · doi:10.1002/0470862092.d0707 · Cited by 1
Flabe, A. H., Luo, J., Foulds, A., Huda, K., Prottoy, N. K., Amirat, S., & Zabeen, B. (2025) · Research Square · doi:10.21203/rs.3.rs-8356318/v1 · Cited by 1
Kern, W. (2010) · Elsevier eBooks · doi:10.1016/b978-3-437-24680-7.10066-2
Hypoglycaemia During Pregnancy in Women with Pregestational Diabetes
Ringholm, L., Damm, P., & Mathiesen, E. R. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch11
Metadata
- Authors
- The Diabetes Control and Complications Trial Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The Diabetes Control and Complications Trial Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-02-01
- Volume
- 46
- Issue
- 2
- Pages
- 271-286
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W4252271922
- Semantic Scholar
- 0b14f6e58470afda31b2a9daa1c3fb61be7dad5a
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 36 · 2015: 47 · 2014: 45 · 2013: 36 · 2012: 33
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, type 1 diabetes, intensive insulin therapy, baseline characteristics, Diabetes Control and Complications Trial, hypoglycemia risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.